Approval · Notice of Compliance 38105 · 2026
IMAAVY: Notice of Compliance 38105
Issued August 13, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38105
- Date
- August 13, 2026
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- additional manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMAAVY | Not yet assigned | — |
Medicinal ingredients
- NIPOCALIMAB 1,200 MG per 6.5ML
- NIPOCALIMAB 300 MG per 1.62ML